Abstract
The diverse activities of dopamine D2-like receptors, including D2, D3, and D4 receptors, are mediated by proteins that interact with the third cytoplasmic loop and regulate receptor signaling, receptor trafficking, and apoptosis. Such interacting proteins include calmodulin, the N-methyl-d-aspartate receptor 2B subunit, calcium/calmodulin-dependent protein kinase II, prostate apoptosis response-4, and β-arrestins, which regulate receptor signaling and the pharmacological action through D2 receptor. The gene encoding the D2 receptor gives rise to two isoforms, termed the dopamine D2 receptor long isoform (D2L) and the dopamine D2 receptor short isoform; the latter lacks 29 amino acids of the D2L receptor within the third cytoplasmic loop. In this review, we first focus on novel functions of the hetero-oligomeric D1/D2 and D2/adenosine A2A receptors. We next discuss novel signaling through proteins interacting with the D2 receptor third cytoplasmic loop and define the function of a novel binding protein, heart-type fatty acid binding protein, which interacts with the D2L third cytoplasmic loop.
Similar content being viewed by others
Abbreviations
- ACh:
-
Acetylcholine
- CaM:
-
Calmodulin
- CaMKII:
-
Calcium/calmodulin-dependent protein kinase II
- DAT:
-
Dopamine transporter
- DHA:
-
Docosahexaenoic acid
- EPA:
-
Eicosapentaenoic acid
- Glu:
-
Glutamate
- H-FABP:
-
Heart-type fatty acid binding protein
- LCPUFA:
-
Long chain polyunsaturated fatty acid
- LTP:
-
Long-term potentiation
- MSN:
-
Medium-sized spiny neuron
- NMDA:
-
N-methyl-d-aspartate
- NR2B:
-
NMDA receptor 2B subunit
- NSF:
-
N-ethylmaleimide-sensitive factor
- Par-4:
-
Prostate apoptosis response-4
References
Missale C, Nash R, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors from structure to function. Physiol Rev 78:189–225
Sidhu A, Niznik HB (2000) Coupling of dopamine receptor subtypes to multiple and diverse G proteins. Int J Dev Neurosci 18:669–677
Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, O’Dowd BF, George SR (2007) D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA 104:654–659
So CH, Verma V, Alijaniaram M, Cheng R, Rashid AJ, O’Dowd BF, George SR (2009) Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers. Mol Pharmacol 75:843–854
Oak JN, Lavine L, Van Tol HHM (2001) Dopamine D4 and D2L receptor stimulation of the mitogen-activated protein kinase pathway id dependent on trans-activation of the platelet-derived growth factor receptor. Mol Pharmacol 60:92–103
Dal Toso R, Sommer B, Ewert M, Herb A, Pritchett DB, Bach A, Shivers BD, Seeburg PH (1989) The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J 8:4025–4034
Itokawa M, Arinami T, Futamura N, Hamaguchi H, Toru M (1993) A structural polymorphism of human dopamine D2 receptor, D2 (Ser311→Cys). Biochem Biophys Res Commun 196:1369–1375
Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H, Hamaguchi H, Toru M (1994) Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 343:703–704
Laurent C, Bodeau-Pean S, Campion D et al (1994) No major role for the dopamine D2 receptor Ser → Cys311 mutation in schizophrenia. Psychiatr Genet 4:229–230
Cravchik A, Sibley DR, Gejman PV (1996) Functional analysis of the human D2 dopamine receptor missense variants. J Biol Chem 271:26013–26017
Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R et al (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 104:20552–20557
Zhang L, Yang H, Zhao H, Zhao C (2011) Calcium-related signaling pathways contributes to dopamine-induced cortical neuron apoptosis. Neurochem Internat 58:281–294
Fiorentini C, Busi C, Spano P, Missale C (2010) Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function. Curr Opin Phamacol 10:87–92
Perreault ML, Hasbi A, Alijaniaram M, Fan T, Varghese G, Fletcher PJ, Seeman P, O’Dowd BF, George SR (2010) The dopamine D1–D2 receptor heteromer localizes in dynorphin/encephalin neurons. J Biol Chem 285:36625–36634
Ferré S, Woods AS, Navarro G, Aymerich M, Lluis C, Franco R (2010) Calcium-mediated modulation of the quaternary structure and function of adenosine A2A-dopamine D2 receptor heteromers. Curr Opin Pharmacol 10:67–72
Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferré S (2007) Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol 83:277–292
Azdad K, Gall D, Woods AS, Ledent C, Ferré S, Schiffmann SN (2009) Dopamine D2 and A2A receptors regulate NMDA-mediated excitation in accumbens neurons thorugh A2A-D2 receptor heteromerization. Neuropsychopharmacol 34:972–986
Xu K, Bastia E, Schwarzschild M (2005) Therapeutic potential of adenosin2 A2A receptor antagonists in Parkinson’s disease. Pharmacol & Therapeutics 105:267–310
Navarro G, Aymeric MS, Marcellino D, Cortes A, Casado V, Mallol J, Canela EI, Agnati LF, Woods AS, Fuxe K et al (2009) Interactions between calmodulin, adenosine A2A and dopamine D2 receptors. J Biol Chem 284:28058–28068
Bofill-Cardona E, Kudlacek O, Yang Q, Ahorn H, Freissmuth M, Nanoff C (2000) Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch. J Biol Chem 275:32672–32680
Rhoads AR, Friedberg F (1997) Sequence motifs for calmodulin recognition. FASEB J 11:331–340
Liu XY, Mao LM, Zhang GC, Papasian CJ, Fibuch EE, Lan HX, Zhou HF, Xu M, Wang JQ (2009) Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII. Neuron 61:425–438
Collingridge GL, Singer W (1990) Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol Sci 11:290–296
Liu XY, Chu XP, Mao LM, Wang M, Lan HX, Li MH, Zhang GC, Parelkar NK, Fibuch EE, Haines M, Neve KA, Liu F, Xiong ZG, Wang JQ (2006) Modulation of D2R–NR2B interactions in response to cocaine. Neuron 52:897–909
Ouimet CC, McGuinness TL, Greengard P (1984) Immunocytochemical localization of calcium/calmodulin-dependent protein kinase II in rat brain. Proc Natl Acad Sci USA 81:5604–5608
Fukunaga K, Stoppini L, Miyamoto E, Muller D (1993) Long-term potentiation is associated with an increased activity of Ca2+/calmodulin-dependent protein kinase II. J Biol Chem 268:7863–7867
Ng J, Rashi AJ, So CH, O’Dowd BF, George SR (2010) Activation of CaMKIIα in the striatum by the heteromeric D1/D2 dopamine receptor complex. Neuroscience 165:535–541
Lee K-W, Kim Y, Kim AM, Helmin K, Nairn AC, Greengard P (2006) Cocaine-induced dendric spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proc Natl Acad Sci USA 103:3399–3404
Shioda N, Beppu H, Fukuda T, Li E, Kitajima I, Fukunaga K (2011) Aberrant calcium/calmodulin-dependent protein kinase II (CaMKII) activity is associated with abnormal dendritic spine morphology in the ATRX mutant mouse brain. J Neurosci 31:346–358
Sells SF, Wood DP Jr, Joshi-Barve SS, Muthukumar S, Jacob RJ, Crist SA, Humphreys S, Rangnekar VM (1994) Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ 5:457–466
Park SK, Nguyen MD, Fischer A, Luke MP, Affar el B, Dieffenbach PB, Tseng HC, Shi Y, Tsai LH (2005) Par-4 links dopamine signaling and depression. Cell 122:275–287
Glantz LA, Gilmore JH, Overstreet DH, Salimi K, Lieberman JA, Jarkog LF (2010) Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression. Schizophrenia Res 118:292–299
Guiramand J, Montmayeur JP, Ceraline J, Bhatia M, Borrelli E (1995) Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins. J Biol Chem 270:7354–7358
Prou D, Gu WJ, Le S, Vincent JD, Salamero J, Vernier P (2001) Intracellular retention of the two isoforms of the D(2) dopamine receptor promotes endoplasmic reticulum disruption. J Cell Sci 114:3517–3527
Takeuchi Y, Fukunaga K (2003) Differential subcellular localization of two dopamine D2 receptor isoforms in transfected NG108-15 cells. J Neurochem 85:1064–1074
Takeuchi Y, Fukunaga K, Miyamoto E (2002) Activation of nuclear Ca2+/calmodulin-dependent protein kinase II and brain-derived neutropic factor gene expression by stimulation of dopamine D2 receptor in transfected NG108-15 cells. J Neurochem 82:316–328
Shioda N, Yamamoto Y, Watanabe M, Binas B, Owada Y, Fukunaga K (2010) Heart-type fatty acid binding protein regulates dopamine D2 receptor function in mouse brain. J Neurosci 30:3146–3155
Bertran-Gonzalez J, Bosch C, Maroteaux M, Matamales M, Hervé D, Valjent E, Girault JA (2008) Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 28:5671–5685
Welter M, Vallone D, Samad TA, Meziane H, Usiello A, Borrelli E (2007) Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine. Proc Natl Acad Sci USA 104:6840–6845
Cepeda C, Hurst RS, Altemus KL, Flores-Hernández J, Calvert CR, Jokel ES, Grandy DK, Low MJ, Rubinstein M, Ariano MA, Levine MS (2001) Facilitated glutamatergic transmission in the striatum of D2 receptor-deficient mice. J Neurophysiol 85:659–670
Gill RS, Hsiung MS, Sum CS, Lavine N, Clark SD, Van Tol HHM (2010) The dopamine D4 receptor activates intracellular platelet-derived growth factor receptor b to stimulate ERK1/2. Cell Signaling 22:285–290
Robben JH, Kortenoeven ML, Sze M, Yae C, Milligan G, Oorschot VM, Klumperman J, Knoers NV, Deen PM (2009) Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists. Proc Natl Acad Sci U S A 106:12195–12200
Jean-Alphonse F, Hanyaloglu AC (2011) Regulation of GPCR signal networks via membrane trafficking. Mol Cell Endcrinol 331:205–214
Maier O, Ehmsen E, Westermann P (1995) Trimetric G protein α subunits of the Gs and Gi families localized at the Golgi membrane. Biochem Biophy Res Commun 208:135–143
Hanson PI, Otto H, Barton N, Jahn R (1995) The N-ethylmaleimide-sensitive fusion protein and alpha-SNAP induce a conformational change in syntaxin. J Biol Chem 270:16955–16961
Nishimune A, Isaac JT, Molnar E, Noel J, Nash SR, Tagaya M, Collingridge GL, Nakanishi S, Henley JM (1998) NSF binding to GluR2 regulates synaptic transmission. Neuron 21:87–97
Zou S, Li L, Pei L, Vukusic B, Van Tol HH, Lee FJ, Wan Q, Liu F (2005) Protein–protein coupling/uncoupling enables dopamine D2 receptor regulation of AMPA receptor-mediated excitotoxicity. J Neurosci 25:4385–4395
Lee FJ, Pei L, Moszczynska A, Vukusic B, Fletcher PJ, Liu F (2007) Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J 26:2127–2136
Smith FD, Oxford GS, Milgram SL (1999) Association of the D2 dopamine receptor third cytoplasmic loop with spinophilin, a protein phosphatase-1-interacting protein. J Biol Chem 274:19894–19900
Feng J, Yan Z, Ferreira A, Tomizawa K, Liauw JA, Zhou M, Allen PB, Ouimat CC, Greenfard P (2000) Spinophilin regulates the formation and function od dendritic spines. Proc Natl Acad Sci USA 97:9287–9292
Yao WD, Spealman RD, Zhang J (2008) Dopaminergic signaling in dendritic spines. Biochem Pharmacol 75:2055–2069
Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG (2004) Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27:107–144
Beaulieu JM, Sotnikova TD, Merion S, Lefkowitz RJ, Gainetdinov RR, Caron MG (2005) An Aktβ-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122:261–273
Kim K-M, Caron MG (2008) Complementary roles of the DRY motif and C-terminus tail of GPCRs for G protein coupling and β-arrestin interaction. Biochem Biophy Res Commun 366:42–47
Li Y-C, Gao W-J (2011) GSK-3β activity and hyperdopamine-dependent behaviors. Neurosci Biobehav Reviews 35:645–654
Peet M, Laugharne J, Rangarajan N, Horrobin D, Reynolds G (1995) Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients. J Psychiatr Res 29:227–232
Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP (2003) Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res 62:195–204
Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, Kiso Y, Sakakibara M, Yoshimoto T, Guo J, Yamashima T (2006) Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res 56:159–164
Horrocks LA, Yeo YK (1999) Health benefits of docosahexaenoic acid (DHA). Pharmacol Res 40:211–225
Owada Y, Yoshimoto T, Kondo H (1996) Spatio-temporally differential expression of genes for three members of fatty acid-binding proteins in developing and mature rat brains. J Chem Neuroanat 12:113–122
Murphy EJ, Owada Y, Kitanaka N, Kondo H, Glatz JFC (2005) Brain arachidonic acid incorporation is decreased in heart fatty acid binding protein gene-ablated mice. Biochemistry 44:6350–6360
Arai Y, Funatsu N, Numayama-Tsuruta K, Nomura T, Nakamura S, Osumi N (2005) Role of Fabp7, a downstream gene of Pax6, in the maintenance of neuroepithelial cells during early embryonic development of the rat cortex. J Neurosci 25:9752–9761
Watanabe A, Toyota T, Owada Y, Hayashi T, Iwayama Y, Matsumata M, Ishitsuka Y, Nakaya A, Maekawa M, Ohnishi T, Arai R, Sakurai K, Yamada K, Kondo H, Hashimoto K, Osumi N, Yoshikawa T (2007) Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol 5:e297
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fukunaga, K., Shioda, N. Novel Dopamine D2 Receptor Signaling through Proteins Interacting with the Third Cytoplasmic Loop. Mol Neurobiol 45, 144–152 (2012). https://doi.org/10.1007/s12035-011-8227-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-011-8227-8